We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

The FDA released a summary report outlining its strategy for preventing the spread of human norovirus and hepatitis A outbreaks due to fresh and frozen berries. After several issues with berries being ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

In addition, if you are pregnant, speak with your healthcare provider about which vaccine is right for you. Hepatitis B is a viral infection that causes inflammation of the liver. In rare cases, ...

Hepatitis B is inflammation of the liver in hominoidea, including humans, caused by the hepatitis B virus. The virus is transmitted by parenteral exposure, such as by exposure to infectious blood ...